Originally published in Volume 43 Issue 8 of Artificial Organs, 07 August 2019
In 1943, Willem Kolff (1911-2009) initiated hemodialysis in patients in The Netherlands and is considered a pioneer of dialysis treatment. However, Nils Alwall (1904-1986) of Lund, Sweden, built a dialysis apparatus a few years before Kolff, and greatly contributed to understanding the clinical aspects of dialysis therapy. His first experiments with laboratory animals (rabbits) date to the end of 1941. Alwall made a series of improvements to his original model of artificial kidney (“dialyzer-ultrafilter”) and the result was in fact the first serially produced apparatus in the world, with a wide therapeutic application. Seventy years have just passed since this dialyzer was introduced to clinical use in 1949. Before, Alwall performed numerous experiments with various apparatuses, whose structure evolved from a plate-type to a cylindrical apparatus with a spirally wound cellophane tube (semipermeable membrane). No sooner than 15 years later, in the mid-1960s, came the era of disposable dialysis filters (Figure 1).
Figure 1

Figure 2

Figure 3

Figure 4
Only a few dialyzers of this type were made for the dialysis ward in Lund, its cost ($120) was equivalent to Alwall’s monthly scholarship. Due to the growing interest in other countries in 1947-1948, Alwall was asked about a possible availability of the dialyzers. One was loaned to a hospital in Copenhagen and another one was sent to Krakow, Poland. The diagrams and guidelines for use were sent to several other countries where copies of the dialyzer were built. In Israel a modified model was built and used in patients with acute renal failure.1
The design of Alwall’s dialyzer was simple, but the manufacturing required qualified workmanship. Each part of the dialyzer in contact with the cellophane membrane had to be perfectly smooth to prevent puncturing. The precision of performance was crucial because Alwall planned to carry out ultrafiltration with a negative pressure in the dialysate, which he thought was less harmful to blood cells. In this process, the cover of the cylinder with the wound cellophane membrane had to be tightly fitted. Alwall was looking for a manufacturer but in 1947 the demand for dialyzers was limited. In the end, Hilding Ståhlbrandt, the director of the Rubber Manufacturers in Trelleborg, agreed to build several models for research in rabbits. These apparatuses, made of hardened rubber (Ebonite) were used in Lund in 1947 and were evaluated positively regarding the effectiveness of dialysis, and ultrafiltration with a negative pressure in the dialysate compartment (Figure 3B). This prompted the development of a larger apparatus for use in patients (Figure 4B). The negative pressure up to 1 atmosphere in a closed, external cylinder with a dialysate was obtained initially by exposing a draining tube with the dialysate from the upper floor window (siphon mechanism); later a vacuum pump was applied. In this apparatus 3 segments of cellophane tubes of different length could be used, depending on the patient’s weight. The manufacturer was generous and Alwall was covering only 20% of the of prototype cost. This model was used in 59 patients in the years 1948-1949.2
A steam chamber was used for sterilization of the apparatus. Unfortunately, exposure to hot steam eventually deformed the dialyzer, so in 1948 Alwall managed to come in contact with Axel Axelson Johnson, chairman of the Johnson Metal Group, and production of a stainless steel dialyzer was started at the Swedish Metal Plant Avesta Jernverk AB. Axel Johnson was enthusiastic about “this significant medical activity.” The basic design was first that of the Ebonite dialyzer from Trelleborg. The first stainless steel models for rabbit experiments (Figure 3C) were provided in February 1949. Then, a larger dialyzer was developed for treatment of patients (Figure 5A). It consisted of 2 perforated cylinders. A cellophane tube, 20-21 m in length (dialysis surface of 1.6 m2) was wound on the smaller one, and the larger cylinder compressed the cellophane tube. The dialysate was mixed by an electric motor placed on a tight Plexiglass cover. The construction was gradually improved and after 1952 the models became bigger. An illumination of the inter-cylinder space was provided to detect possible leaking of the blood into the dialysate in case of perforation of the cellophane tube. After 1957 a cellophane tube of 30-40 m in length (dialysis surface up to 2.7 m2) could be wound (Figure 5B); however, 20-m tubes were commonly used.3 Ultrafiltration could remove about 1 L fluid per hour from the circulating blood. The dialysate in the outer cylinder (volume of 130-140 L) was changed every 2 hours by a stainless steel pipe system connected to the main dialysate reservoir of 850 L. Tap water was treated in softening columns and pH 7.4 in the dialysate was maintained using the carbonic/bicarbonate buffer system. Four composition variants of the dialysate were used, as needed, eg, low-sodium dialysate could be prepared beginning in 1951. A peristaltic roller pump (“sigma pump”) was used to deliver blood. In the years 1949-1965, the Avesta dialyzer was used in over 3000 human treatments in Lund.1, 2
Figure 5
The original dialyzer built at the Institute of Physiology and at first used in Alwall’s dialysis ward in 1946 was later replaced with Ebonite dialyzer until in 1949 an Avesta dialyzer was installed, and another one was added in 1953. By 1957 three Avesta dialyzers were in use. In 1966, 2 dialysis monitors and coil filters were provided by Gambro for clinical testing. Between 1949 and 1966, the Avesta factory produced dialyzers at the initial cost of about $3500. The interest in the world was significant, the waiting time for delivery reached several months, and Alwall was asked to intervene at Avesta Jernverk. These dialyzers had been purchased by about 50 dialysis centers in over 20 countries on 5 continents; Egypt, Kuwait, Mexico, China, the Soviet Union, Cuba, South Africa, USA, India, Australia, Japan, and in many European countries. Five dialyzers were sold to Germany, and 3 to Poland, Switzerland and Denmark each. At the end of the 1960s, they were still in use in 40 dialysis centers.2 The results of acute renal failure treatment with dialysis were considered so effective that in 1956 a Swedish insurance company bought three Avesta dialyzers for a total sum of $20 000 and donated them to three hospitals in Sweden (Göteborg, Stockhom and Umeå). Apparently, the Avesta dialyzer was one of the most frequently bought in these early years of dialysis therapy of acute and later also of chronic renal failure, and it proved relatively efficient for dialysis and ultrafiltration: the disadvantages were that it was heavy, not suitable for treatment outside the dialysis center, required intensive work of the staff, moreover, the cellophane membrane was often perforated during the winding up and the process had to be repeated. The contact of the used materials with blood led to pyrogenic reactions. Despite the volume reduction of the cellophane tube, the apparatus still required about 1.5 L of preserved blood from many donors and post-transfusion reactions were not uncommon. In practice, it could be used only once in a day, because the preparation for the treatment (washing, winding up, folding, and sterilization) required about 4 hours compared to the treatment duration of 6-10 hours. It was still possible to carry out 2 treatments within 24-hours using the same dialyzer but the workload on the staff was heavy, especially at nights. Despite these drawbacks, the dialyzer had been in use until the mid-1960s (over 15 years), when new possibilities emerged. Nevertheless, owing to the availability of Avesta dialyzers at that time, in numerous countries generations of doctors and dialysis personnel had an opportunity of specialized training.
Alwall was aware of the inadequacy of this dialyzer, of the growing demand for dialysis treatment as well as of ongoing debates and attempts to construct a simple disposable dialysis filter. An optimal solution would be if such filters were delivered to the dialysis ward ready for use, in sealed packing, after sterilization. The chance arose in 1961 when Alwall met Holger Crafoord, the director and shareholder of Åkerlund & Rausing and later of the Tetra Pak Company in Lund, the one which introduced the famous packing for fluids into the world market. They debated at length the status of treatment using available dialyzers, the situation of patients with renal failure, and the need for adequate, simple, and safe equipment for dialysis. Crafoord was fascinated by Alwall’s enthusiasm and commitment to saving patients’ life and decided to finance the project. Obviously, Alwall, as an inspirer and proponent became the main designer and consultant. Initially, the construction work was focused on the coil dialysis filter, carried out at the cooperating A. B. ARJO Company, located in the town of Eslöv, near Lund. The initial prototypes dated to 1962 (Figure 6, upper panel) were not successful, but a new construction consisting usually of 4 coil units, with 5 m length of a cellophane tube each, and total dialysis surface of 1.0 m2 (filter weight: 10.2 kg)4 proved satisfactory when tested at Alwall’s Nephrology Department in August 1964 (Figure 6, lower panel). Two or 3 units could be put together when planning a dialysis procedure in a child. However, these filters were not disposable, they required priming with the donor blood and were expensive to use. After each dialysis procedure they were sent to ARJO for exchange of the cellophane membrane and sterilization, and then returned to the dialysis ward. In total, 20 of such filters were produced and were in continuous circulation; they were used in about 400 hemodialysis procedures in 1966. The total cost of creation of the prototype of this filter was about $9000.2
Figure 6
In October 1964, the company A.B. Gambro was established: The name Gambro came from the abbreviation of the Gamla Brogatan (Old Bridge) Street in Stockholm, where Crafoord’s “Old Bridge Street Medical Supplies Company A.B. was located. In 1965-1966, Crafoord sold his shares in Åkerlund & Rausing and in Tetra Pak and became exclusively involved in the development of Gambro which was extended by purchasing of A.B. Instrumenta in Lund, manufacturers of various medical devices, including respirators. This company took up the construction of AK (Artificial Kidney)—dialysis monitor, partially at the premises of ARJO. Also here, Alwall enforced the clinical need for these dialysis devices (monitoring 7 clinical and technical parameters of the procedure) and clinically tested 2 AK 1, using coil dialysis filters, in 1966. The market price of the AK 1 monitor was about $8000.2
The new ward of 14 bed sites, each equipped with AK 1 monitors opened in 1968; it was one of the most modern in the world.
In 1965, work was started to develop a disposable plate filter based on Kiil’s dialyzer used in the 1960s, the one which required the exchange of cellophane membrane before each treatment. The first prototype of the Gambro plate filter was considered unsuccessful (Figure 7A). The subsequent model consisting of metal and plastic parts with a dialysis membrane (Cuprophane) surface of 1.0 m2 proved satisfactory, and despite its considerable weight (7.5 kg), dimensions (590 × 165 × 110 mm), relatively high price ($100 each) entered serial production in 1967 under the name “Ad Modum Alwall” (Figure 7B).4 The advantage of this plate filter was a small blood volume of 200-300 mL and low resistance in the blood chamber so that the priming with donor’s blood before the start of dialysis was not necessary. The treatment within 7-8 hours gave similar dialysis results as a 12-13 hours’ treatment using Kiil’s dialyzer. It was the first model of a disposable plate dialysis filter in the world. Introduction of the “Ad Modum Alwall” filter gave rise to a spectacular development of Gambro, which obtained space in Lund for the construction of its own headquarters. The production of dialysis filters and monitors was transferred from ARJO in Eslöv to Gambro in Lund in 1970/1971, and the cooperation with ARJO was closed in the next year. Gambro was getting more consolidated and all the work on new models of dialysis filters and monitors was taken over by a team of engineers, technicians, medical, and administrative staff. A new model of a disposable plate filter, the first in the world made entirely of plastic materials but still based on the experience acquired with the filter “Ad Modum Alwall,” was developed by the Gambro team and was launched in 1972 as “Gambro Lundia” (Figure 7C); its membrane surface was 0.54-1.0 m2 and the weight 2.0-2.6 kg.4

Figure 7
Alwall retired in 1971, but he remained a consultant at Gambro until 1984, and cooperation between Gambro and the Nephrology Department in Lund continued, and included clinical assessment of the produced dialysis filters and monitors. In January 1985, the new Gambro Research Center in Lund called “Alwall Laboratory” was opened in the presence of Alwall.
A more thorough presentation of Nils Alwall’s activity as a visionary, originator, designer, and researcher of the clinical aspects of hemodialysis was given recently.5 His persistent efforts and hard work on the development of this form of treatment of kidney failure helped a great number of patients to improve their fate and let them live longer. In Sweden, he got the nickname “Man of a Miracle.”6
Biographies
Jan Kurkus, MD, PhD graduated from the Warsaw Medical School 1962 and since 1964 was a staff member of the Department of Internal Medicine, Warsaw Medical School Hospital. He attained his PhD in 1972. He also studied at the Memorial Sloan-Kettering Cancer Center, New York, NY, USA in 1975/1976 (special fellow in medicine) and 1982 (visiting investigator). Since 1985, he was a staff member of the Department of Nephrology, University Hospital of Lund, Sweden. The last positions he held were Head of the Dialysis Ward, Senior Consultant, and Associate Professor. He is presently retired.
Janusz Ostrowski, MD, PhD is a nephrologist and PD Medical Director for Diaverum Poland, one of the world’s largest independent renal care providers. He is also a Professor at the Centre of Postgraduate Medical Education, Warsaw, Poland, Head of the Department of History of Medicine as well as President of the International Association for the History of Nephrology.